157 related articles for article (PubMed ID: 31013556)
1. 2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What's Different?
Kim JH
Korean J Gastroenterol; 2019 Mar; 73(3):132-140. PubMed ID: 31013556
[TBL] [Abstract][Full Text] [Related]
2. KASL Clinical Practice Guidelines: Management of chronic hepatitis B.
Korean Association for the Study of the Liver
Clin Mol Hepatol; 2012 Jun; 18(2):109-62. PubMed ID: 22893865
[TBL] [Abstract][Full Text] [Related]
3. KASL clinical practice guidelines for management of chronic hepatitis B.
Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol; 2019 Jun; 25(2):93-159. PubMed ID: 31185710
[No Abstract] [Full Text] [Related]
4. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
Caruntu FA; Gheorghita V
J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
[No Abstract] [Full Text] [Related]
5. KASL clinical practice guidelines: management of chronic hepatitis B.
Korean Association for the Study of the Liver
Clin Mol Hepatol; 2016 Mar; 22(1):18-75. PubMed ID: 27044762
[No Abstract] [Full Text] [Related]
6. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
Fung J; Lai CL; Yuen MF
Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
[TBL] [Abstract][Full Text] [Related]
7. Management of chronic hepatitis B: an update.
Negro F
Swiss Med Wkly; 2011; 141():w13264. PubMed ID: 21913139
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update.
Tong MJ; Hsu L; Chang PW; Blatt LM
J Gastroenterol Hepatol; 2011 May; 26(5):829-35. PubMed ID: 21214888
[TBL] [Abstract][Full Text] [Related]
9. Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.
Coffin CS; Fung SK; Ma MM;
Can J Gastroenterol; 2012 Dec; 26(12):917-38. PubMed ID: 23248795
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection--natural history and clinical consequences.
Ganem D; Prince AM
N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
[No Abstract] [Full Text] [Related]
11. [Is quantification of HBsAg levels useful in the follow-up of patients with chronic hepatitis B virus infection?].
Romero M; Madejón A; García-Samaniego J
Gastroenterol Hepatol; 2014; 37(6):350-3. PubMed ID: 24698803
[No Abstract] [Full Text] [Related]
12. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):938-961. PubMed ID: 31941257
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop.
Yim HJ; Kim JH; Park JY; Yoon EL; Park H; Kwon JH; Sinn DH; Lee SH; Lee JH; Lee HW
Clin Mol Hepatol; 2020 Oct; 26(4):411-429. PubMed ID: 32854458
[TBL] [Abstract][Full Text] [Related]
14. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.
Su TH; Hsu CS; Chen CL; Liu CH; Huang YW; Tseng TC; Liu CJ; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2010; 15(8):1133-9. PubMed ID: 21149920
[TBL] [Abstract][Full Text] [Related]
15. Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg.
Lee JH; Kim SJ; Ahn SH; Lee J; Park Y; Kim HS
J Clin Pathol; 2010 Nov; 63(11):1027-31. PubMed ID: 20870658
[TBL] [Abstract][Full Text] [Related]
16. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
Tong MJ; Hsien C; Hsu L; Sun HE; Blatt LM
Hepatology; 2008 Oct; 48(4):1070-8. PubMed ID: 18688879
[TBL] [Abstract][Full Text] [Related]
17. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
Li J; Sun X; Fang J; Wang C; Han G; Ren W
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
[TBL] [Abstract][Full Text] [Related]
18. Lamivudine for chronic hepatitis B.
Leung N
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):173-80. PubMed ID: 15482184
[TBL] [Abstract][Full Text] [Related]
19. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
20. Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.
Jung KS; Park JY; Chon YE; Kim HS; Kang W; Kim BK; Kim SU; Kim do Y; Han KH; Ahn SH
J Gastroenterol; 2016 Aug; 51(8):830-9. PubMed ID: 26687058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
